Issues Identified
According to FDA analyses and adverse event surveillance, diclofenac, omeprazole, and sometimes also dexamethasone, were hidden drugs in products that were not declared to possess any pharmaceutical ingredients. Adulteration of this type increases the risk of health problems, especially for consumers who take other medications, have co-morbidities, elderly patients, and certain other populations. The FDA is treating all products (including Umary and Amazy) that contain these drugs to be adulterated.